Print this page   Sitemap

The objectives of APME are:

  • ensuring the best possible medical treatment to patients with the help of high-quality effective medicinal products;
  • ensuring the availability of modern medicinal products to patients in Estonia;
  • promoting the patients’ increased awareness of health care and disease prevention as well as of treatment options and the use of medicinal products;
  • securing the balanced development and stability of the Estonian medicinal products market, which involves the protection of intellectual property, promotion of innovation and ensuring a market-environment that is conducive to free enterprise and fair competition.

  • novo-nordisk
  • glaxosmithkline
  • astrazeneca
  • KRKA
  • berlin-chemie-menarini
  • ratiopharm
  • pfizer
  • mepha
  • MEda
  • novartis
  • merck-sharp-dohme
  • janssen-cilag
  • gedeon-richter
  • roche
  • Bayer-cross
  • sanofi-aventis
  • zentiva
  • quintiles50
  • sandoz
  • lundbeck
  • abbott-a-promise-for-life
  • MedFiles 50%
  • nycomed
  • boehringer-ingelheim
  • schering-plough
  • lilly